Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Beaumier

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotinH B Breitz, P L Weiden, P L Beaumier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1993
Dosimetry of rhenium-186-labeled monoclonal antibodies: methods, prediction from technetium-99m-labeled antibodies and results of phase I trialsH B Breitz, D R Fisher, P L Weiden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1986
Immunoreactivity assay for labeled anti-melanoma monoclonal antibodiesP L Beaumier, D Neuzil, H M Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agentA R Fritzberg, P G Abrams, P L Beaumier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1993
Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10P L Weiden, H B Breitz, C A Seiler, et al.
Bioconjugate Chemistry|February 14, 1998
Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate)S Kasina, J A Sanderson, J N Fitzner, et al.
Radiology|May 1, 1985
Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experienceS M Larson, J A Carrasquillo, R W McGuffin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicityD B Axworthy, J M Reno, M D Hylarides, et al.
The Journal of Clinical Investigation|December 1, 1983
Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapyS M Larson, J A Carrasquillo, K A Krohn, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotinH B Breitz, P L Weiden, P L Beaumier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1993
Dosimetry of rhenium-186-labeled monoclonal antibodies: methods, prediction from technetium-99m-labeled antibodies and results of phase I trialsH B Breitz, D R Fisher, P L Weiden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1986
Immunoreactivity assay for labeled anti-melanoma monoclonal antibodiesP L Beaumier, D Neuzil, H M Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agentA R Fritzberg, P G Abrams, P L Beaumier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1993
Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10P L Weiden, H B Breitz, C A Seiler, et al.
Bioconjugate Chemistry|February 14, 1998
Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate)S Kasina, J A Sanderson, J N Fitzner, et al.
Radiology|May 1, 1985
Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experienceS M Larson, J A Carrasquillo, R W McGuffin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicityD B Axworthy, J M Reno, M D Hylarides, et al.
The Journal of Clinical Investigation|December 1, 1983
Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapyS M Larson, J A Carrasquillo, K A Krohn, et al.
Pageof 3